Programmable siRNA pro-drugs that activate RNAi activity in response to specific cellular RNA biomarkers.
Han SP, Scherer L, Gethers M, Salvador AM, Salah MBH, Mancusi R, Sagar S, Hu R, DeRogatis J, Kuo YH, Marcucci G, Das S, Rossi JJ, Goddard WA 3rd.
Han SP, et al.
Mol Ther Nucleic Acids. 2022 Jan 3;27:797-809. doi: 10.1016/j.omtn.2021.12.039. eCollection 2022 Mar 8.
Mol Ther Nucleic Acids. 2022.
PMID: 35116191
Free PMC article.